POSTOPERATIVE PROPHYLACTIC INTRAVESICAL INSTILLATION OF CYTOSINE-ARABINOSIDE AND MITOMYCIN-C IN SUPERFICIAL BLADDER-TUMOR - A FOLLOW-UP-STUDY

被引：11

作者：

OMOTO, T ^{[1
]}

KANO, M ^{[1
]}

ARIYOSHI, A ^{[1
]}

MOMOSE, S ^{[1
]}

MASAKI, Z ^{[1
]}

MORITA, I ^{[1
]}

ISHISAWA, N ^{[1
]}

机构：

[1] KYUSHU UNIV,FAC MED,DEPT UROL,HIGASHI KU,FUKUOKA 812,JAPAN

来源：

UROLOGY | 1982年 / 20卷 / 05期

关键词：

D O I：

10.1016/0090-4295(82)90125-X

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：510 / 514

页数：5

共 50 条

[31] Sequential intravesical bacillus calmette guerin and electromotive Mitomycin-C for high risk superficial bladder cancer: A prospective controlled study
Di Stasi, SM
Giannantoni, A
Stephen, RL
Virgill, G
Giurioli, A
Storti, L
Vespasiani, G
JOURNAL OF UROLOGY, 2004, 171 (04): : 74 - 74
[32] COMBINED INTRAVESICAL CHEMOTHERAPY WITH MITOMYCIN-C AND LOCAL BLADDER MICROWAVE-INDUCED HYPERTHERMIA AS A PREOPERATIVE THERAPY FOR SUPERFICIAL BLADDER-TUMORS - A PRELIMINARY CLINICAL-STUDY
RIGATTI, P
LEV, A
COLOMBO, R
EUROPEAN UROLOGY, 1991, 20 (03) : 204 - 210
[33] LONG-TERM FOLLOW-UP-STUDY OF GASTRIC CANCER-PATIENTS TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY WITH MITOMYCIN-C
NAKAJIMA, T
FUKAMI, A
OHASHI, I
KAJITANI, T
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1978, 16 (05): : 209 - 216
[34] THE VALUE OF UROTHELIAL DYSPLASIAS IN NORMAL LOOKING BLADDER MUCOSA FROM PATIENTS WITH BLADDER-TUMORS - RESULTS OF A PROSPECTIVE-STUDY WITH AND WITHOUT PROPHYLACTIC INTRAVESICAL CHEMOTHERAPY WITH MITOMYCIN-C
MAIER, U
HOLZNER, JH
ONKOLOGIE, 1985, 8 (04): : 232 - 240
[35] EFFECTIVENESS OF POSTOPERATIVE ADJUVANT THERAPY WITH CYTO-TOXIC CHEMOTHERAPY (CYTOSINE-ARABINOSIDE, MITOMYCIN-C, 5-FLUOROURACIL) OR IMMUNOTHERAPY (NEURAMINIDASE-MODIFIED ALLOGENEIC CELLS) IN THE PREVENTION OF RECURRENCE OF DUKES-B AND C COLON CANCERCY
RAINER, H
KOVATS, E
LEHMANN, HG
MICKSCHE, M
RAUHS, R
SEDLACEK, HH
SEIDL, W
SCHEMPER, M
SCHIESSEL, R
SCHWEIGER, B
WUNDERLICH, M
RECENT RESULTS IN CANCER RESEARCH, 1981, 79 : 41 - 47
[36] Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guerin-RIVM and mitomycin C in superficial bladder cancer
Witjes, JA
van der Meijden, APM
Collette, L
Sylvester, R
Debruyne, FMJ
van Aubel, A
Witjes, WPJ
UROLOGY, 1998, 52 (03) : 403 - 410
[37] Ten Weeks versus 6 Weeks Maintenance Intravesical Instillation of Mitomycin-C for Prevention of Recurrence of Ta/T1 Transitional Cell Carcinoma of the Bladder: A Retrospective Study in a Single Institution
Omar, A.
Amirzadah, P.
Khattak, A.
Gana, H.
Chisholm, N.
Jacob, N.
UROLOGY, 2012, 80 (03) : S217 - S218
[38] INTRAVESICAL APPLICATION OF MITOMYCIN-C WITH AND WITHOUT HYALURONIDASE IN THE PREVENTION OF TUMOR REGROWTH AFTER TRANS-URETHRAL RESECTION OF BLADDER-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED STUDY
MAIER, U
BAUMGARTNER, G
WIENER KLINISCHE WOCHENSCHRIFT, 1988, 100 (24) : 23 - 23
[39] INTRAVESICAL THIOTEPA AND MITOMYCIN-C TREATMENT IMMEDIATELY AFTER TRANS-URETHRAL RESECTION AND LATER FOR SUPERFICIAL (STAGES TA AND TIS) BLADDER-CANCER - A PROSPECTIVE, RANDOMIZED, STRATIFIED STUDY WITH CROSSOVER DESIGN
ZINCKE, H
BENSON, RC
HILTON, JF
TAYLOR, WF
JOURNAL OF UROLOGY, 1985, 134 (06): : 1110 - 1114
[40] Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study
Ranjan, Ashish
Misra, Ankit
Sureka, Sanjoy Kumar
Singh, Uday Pratap
JOURNAL OF UROLOGY, 2023, 209 (04):

← 1 2 3 4 5 →